Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–8 of 8 results
Advanced filters: Author: James Neitzel Clear advanced filters
  • This directory was made possible by a unique international collaboration between the 633 scientists whose names appear below. It represents both the first published description of the complete sequence of most chromsomes from Saccharomyces cerevisiae, and the first published overview of the entire sequence. As such, the authors would like future papers referring to the entire sequence and/or its contents to cite this directory; future papers referring to the sequence of individual chromosomes should refer to the papers listed at the head of page 9. The authors’ affiliations appear in the papers describing the individual chromosomes.

    • A. Goffeau
    • R. Aert
    • E. Zumstein
    Editorial
    Nature
    Volume: 387, P: 5
  • The BIN1 SNP rs744373 is associated with higher CSF tau and phosphorylated tau levels. Here the authors show, using PET imaging, that this SNP is associated with tau accumulation in the brain as well as impaired memory in older individuals without dementia.

    • Nicolai Franzmeier
    • Anna Rubinski
    • Ansgar J. Furst
    ResearchOpen Access
    Nature Communications
    Volume: 10, P: 1-12
  • Characterization of ten temperate mycobacteriophages reveals at least five distinct prophage-expressed viral defence systems that interfere with infection by either closely related or unrelated lytic and temperate phages.

    • Rebekah M. Dedrick
    • Deborah Jacobs-Sera
    • Graham F. Hatfull
    Research
    Nature Microbiology
    Volume: 2, P: 1-13
  • miR-132 was shown to drive pathological cardiac remodeling, a hallmark of heart failure. Here, the authors show that an antisense inhibitor of miR-132 has favourable pharmacokinetics, safety-tolerability and preclinical efficacy in mouse and porcine models of heart failure.

    • Ariana Foinquinos
    • Sandor Batkai
    • Thomas Thum
    ResearchOpen Access
    Nature Communications
    Volume: 11, P: 1-10